Brad Schaeffer, former co-owner and CEO of Zachary, La.-based lab company MedComp Sciences, allegedly billed Medicare and Medicaid for testing 15 substances in urine tests regardless of the treatment plan, according to a Nov. 30 news release from the Justice Department.
Mr. Schaeffer allegedly took several actions to perpetuate the fraud, including writing off patients’ copays and paying kickbacks to physicians disguised as laboratory ownership interests.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
